Gut Microbiota Metabolites and Chronic Diseases: Interactions, Mechanisms, and Therapeutic Strategies DOI Open Access

Wen-Wen Liu,

Lei Wang, Jinmei Ou

и другие.

International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(8), С. 3752 - 3752

Опубликована: Апрель 16, 2025

The gut microbiota, shaped by factors such as diet, lifestyle, and genetics, plays a pivotal role in regulating host metabolism, immune function, overall health. diversity balance of the microbiota are closely linked to onset progression various chronic diseases. A growing body evidence has demonstrated that alterations composition, metabolites significantly associated with cardiovascular diseases, including hypertension, atherosclerosis, heart failure; metabolic disorders obesity, type 2 diabetes, dysfunction-associated steatotic liver disease; gastrointestinal conditions like inflammatory bowel disease colorectal cancer. Despite substantial advances microbiome research, challenges remain fully elucidating causal relationships between disease, well translating these insights into clinical applications. This review aims investigate regulatory pathways via which affects health, disease. Additionally, it highlights emerging strategies for prevention treatment conditions, focusing on microbiota-targeted therapies personalized dietary interventions promising approaches improving health outcomes.

Язык: Английский

Soybean 7S Protein/Calcium Phosphate Complexes for Enhanced Probiotic Delivery and Gut Microbial Regulation DOI

Kaining Han,

Guangxin Feng,

Tanghao Li

и другие.

Food Bioscience, Год журнала: 2025, Номер unknown, С. 106383 - 106383

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

The Gut–Heart Axis and Its Role in Doxorubicin-Induced Cardiotoxicity: A Narrative Review DOI Creative Commons
Carolina Rodrigues Tonon, Amanda Gomes Pereira,

Natália Fernanda Ferreira

и другие.

Microorganisms, Год журнала: 2025, Номер 13(4), С. 855 - 855

Опубликована: Апрель 9, 2025

Doxorubicin is a widely used chemotherapy for the treatment of several types cancer. However, its application restricted due to adverse effects, particularly cardiotoxicity, which can progress heart failure—a chronic and debilitating condition. Several mechanisms have been identified in pathophysiology doxorubicin-induced including oxidative stress, mitochondrial dysfunction, inflammation, disruption collagen homeostasis. More recently, dysbiosis gut microbiota has implicated development perpetuation cardiac injury. Studies reported alterations composition abundance during doxorubicin treatment. Therefore, as recent, there new field research order develop strategies involving prevent or attenuate cardiotoxicity since no effective therapy at moment. This narrative review aims provide an update on role intestinal permeability cardiovascular diseases, more specifically cardiotoxicity. Additionally, it seeks establish foundation future targeting alleviate

Язык: Английский

Процитировано

0

The Role of the Gut Microbiota in Heart Failure: Pathophysiological Insights and Future Perspectives DOI Creative Commons
Francisco Epelde

Medicina, Год журнала: 2025, Номер 61(4), С. 720 - 720

Опубликована: Апрель 14, 2025

The gut microbiota has emerged as a crucial player in cardiovascular diseases, including heart failure (HF). Recent studies have highlighted the bidirectional interaction between and heart, often referred to gut–heart axis. Dysbiosis, characterized by alterations microbial composition function, been linked systemic inflammation, metabolic disturbances, impaired homeostasis. This review explores mechanisms through which influences HF, metabolite production, inflammatory pathways, endothelial dysfunction, hormonal modulation, fluid retention, sodium absorption. potential therapeutic implications of modulation diet, probiotics, pharmacological interventions are also discussed. Understanding these could pave way for novel diagnostic strategies management HF. Future research should focus on longitudinal establish causality development personalized microbiota-based interventions.

Язык: Английский

Процитировано

0

Gut Microbiota Metabolites and Chronic Diseases: Interactions, Mechanisms, and Therapeutic Strategies DOI Open Access

Wen-Wen Liu,

Lei Wang, Jinmei Ou

и другие.

International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(8), С. 3752 - 3752

Опубликована: Апрель 16, 2025

The gut microbiota, shaped by factors such as diet, lifestyle, and genetics, plays a pivotal role in regulating host metabolism, immune function, overall health. diversity balance of the microbiota are closely linked to onset progression various chronic diseases. A growing body evidence has demonstrated that alterations composition, metabolites significantly associated with cardiovascular diseases, including hypertension, atherosclerosis, heart failure; metabolic disorders obesity, type 2 diabetes, dysfunction-associated steatotic liver disease; gastrointestinal conditions like inflammatory bowel disease colorectal cancer. Despite substantial advances microbiome research, challenges remain fully elucidating causal relationships between disease, well translating these insights into clinical applications. This review aims investigate regulatory pathways via which affects health, disease. Additionally, it highlights emerging strategies for prevention treatment conditions, focusing on microbiota-targeted therapies personalized dietary interventions promising approaches improving health outcomes.

Язык: Английский

Процитировано

0